#None #securities lawsuit #Rosen Law #Park Ha Corp

Opportunity for Investors in Park Ha Biological Technology Co., Ltd.

The recent announcement from the Rosen Law Firm has caught the attention of investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH). Investors who purchased securities between December 27, 2024, and July 8, 2025, are reminded that they may qualify to be a part of a significant class action lawsuit aimed at addressing alleged misconduct associated with their investments. With the lead plaintiff deadline set for September 28, 2026, this article aims to inform and guide affected investors on the next steps.

What Is the Class Action Lawsuit?

The class action lawsuit arises from concerns that Park Ha Biological Technology made materially false statements and failed to disclose serious adverse facts about its business practices. The lawsuit highlights several critical points:

1. Fraudulent Promotions: Park Ha allegedly was involved in a fraudulent stock promotion scheme that misled investors through misinformation circulated on social media platforms, including impersonated financial professionals.
2. False Statements: The public statements made by Park Ha during the class period allegedly failed to address significant trading activities impacting the stock price, which were not disclosed in their risk assessments.
3. IPO Concerns: The IPO of Park Ha was reportedly structured in such a way that it created an artificially low public float. This tactic allegedly facilitated market manipulation, which ultimately misled investors.
4. Misleading Information: Positive statements made by the company regarding its operations and future potential came under scrutiny for lacking a sound factual basis.

What Does It Mean for Investors?

For investors who bought shares during the specified timeframe, the opportunity to join the class action could result in compensation for their losses, with no upfront fees or costs involved due to a contingency fee arrangement suggested by Rosen Law Firm. This means that if the case is successful, the legal fees will be paid from any settlements or verdicts recovered, leaving investors with little financial risk in pursuing justice.

How to Participate in the Class Action

Investors who are eligible to participate in the class action can take the following steps:

• - Visit the Rosen Law Firm's Official Page: To join the Park Ha class action, individuals can navigate to rosenlegal.com for registration.
• - Contact the Legal Team: For those who may have queries, Phillips Kim, Esq. can be reached toll-free at 866-767-3653 or via email at [email protected].
• - Consider Lead Plaintiff Role: Interested investors wishing to serve as lead plaintiffs must file their motions with the court by the September 28th deadline.

Choose the Right Legal Counsel

Rosen Law Firm emphasizes the importance of selecting experienced legal representatives when it comes to securities class actions. The firm has an extensive track record and has previously achieved significant settlements for investors, specifically in cases involving securities from Chinese companies. This highlights the necessity for investors to engage with firms that have proven capabilities in handling similar litigation.

What’s Next?

Currently, no class has been certified, meaning that unless investors take formal action, they are not represented. Joining the class action provides an avenue for restitution as a collective while ensuring that their claims are formally recognized.

As this case unfolds, updates are available on the Rosen Law Firm’s social media channels, ensuring that investors stay informed about the ongoing developments.

Investors of Park Ha Biological Technology should take heed and consider engaging with this opportunity promptly to safeguard their interests within this unfolding legal scenario.